At a glance
ClinicalIndex Comparison RecordN/ACompleted· 40 enrolled
Drug / intervention
AXIOSdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multicenter, Single-arm Study of Endoscopic Ultrasound-Guided Drainage of Walled-off Pancreatic Necrosis With Lumen-Apposing Metal Stents
In Brief
A clinical study evaluating AXIOS for Walled Off Pancreatic Necrosis. Completed, enrolled 40 participants across 5 sites.
Detailed Summary
To demonstrate safety and effectiveness of lumen-apposing metal stents for resolution of walled off pancreatic necrosis (WONs) in patients with WONs with solid component \>30%.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsWalled Off Pancreatic Necrosis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedMay 2018
Enrollment StartSep 2018
Primary CompletionMar 2020
Study CompletionOct 2020
TodayJul 2026
First PostedMay 16, 2018
Enrollment StartSep 5, 2018
Primary CompletionMar 31, 2020
Study CompletionOct 2, 2020
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 8.1 years ago
Interventions
AXIOSdevice
Patient will receive either transgastric or transduodenal endoscopic drainage for walled-off necrosis that are adherent to the gastric or bowel wall.